In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Medical Services Patients & Visitors Health Library For Medical Professionals Quality About Us PhysicianLink
Text Size:  -   +  |  Print Page  |  Email Page

Neurology & Stroke Research



Research is one of the components that make us unique at Baptist Health Lexington.  Our highly trained staff is dedicated to providing the latest innovations and newest therapies in a community-based setting.  We are working to improve the lives of our stroke and neurological patients.

Below is a listing of current stroke/neurology clinical trials:

IRB# 555 CREST closed to enrollment in follow up:
Randomized trial for carotid revascularization by endarterectomy or stenting.  

Patients that were eligible could not be high risk for surgery. Could be either symptomatic or asymptomatic.

Will be followed for up to 10 years.

IRB# 1025 The Stanford Registry:

This study that collects routine clinical data and outcomes of patients who have intracranial stents placed for treatment of intracranial aneurysms. This data is being collected in an effort to determine if differences in outcomes are observed based on routine drug dosing and testing.

For additional information please contact Linda Breathitt or Sara Birk at 859-260-6344.

 IRB# 1080 SWIFT:

A global, multi-center, two-arm, prospective, randomized, open, blinded endpoint IDE study to determine if subjects experiencing an acute ischemic stroke due to a large vessel occlusion, treated with combined IV TPA and Solitaire FR (mechanical thrombectomy intervention) within 6 hours of symptom onset have less stroke related disability than those subjects treated with TPA alone. Patients will be followed for 90 days.

For additional information please contact Linda Breathitt or Sara Birk at 859-260-6344.

IRB# 1076 Aspire:

A global multi-center single arm observational registry, for patients who have had a brain aneurysm (a bulge in a blood vessel in your head) that requires or will require a surgical procedure with the  Pipeline Embolization Device or PED which is placed in the artery where the aneurysm occurred. The PED is an approved device. This means that the device was approved for use in the United States, countries in Europe, and other areas of the world.

 A research registry collects information from your medical records in order to analyze the data.  Past, current and future medical information about your treatment of the brain aneurysm will be collected. By collecting the medical information about many patients, such as you, with a brain aneurysm, researchers will be able to increase their knowledge about neurovascular disease. Neurovascular disease is a disease that affects both the nerves and the blood vessels.  Patients will be followed for 60 months.

For additional information please contact Linda Breathitt or Sara Birk at 859-260-6344.

 IRB# 1131 Weave:

The research study is a post market surveillance study of the   Wingspan® Stent System with Gateway® Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter, also known as the WEAVE™ Trial.  The Wingspan Stent System with Gateway PTA Balloon Catheter is a Humanitarian Use Device (HUD).  A HUD is a device used to diagnose or treat a disease or condition that affects fewer than 4,000 individuals in the United States (U.S.) per year and for which no comparable device is available.  The U.S. Food and Drug Administration (FDA) approves the use of HUD devices to give patients a treatment option that may potentially benefit them.  HUD devices have not been proven to provide benefit. 

The purpose of this research study is to fulfill a FDA requirement to collect information on the use of Wingspan Stent System with Gateway PTA Balloon Catheter.  The information to be collected will include the results of the procedure to better understand the benefits and risks of the Wingspan Stent System with Gateway PTA Balloon Catheter.

This research study is being sponsored by Stryker Neurovascular. 

For additional information please contact Linda Breathitt or Sara Birk at 859-260-6344.

 IRB # 1114 Transform:

The main purpose of this registry is to collect data on the use of the TransForm Occlusion Balloon Catheter (OBC) when it is used during procedures on the vessels in the brain (neurovascular procedure). The TransForm OBC is cleared by the FDA for use in brain vessels (neurovasculature) to temporarily stop or control blood flow and for balloon assisted embolization (coiling) of aneurysms. Your doctor can use the TransForm OBC outside of this registry. This registry will look at how the TransForm OBC is used and performs.

This research study is being sponsored by Stryker Neurovascular. 

For additional information please contact Linda Breathitt or Sara Birk at 859-260-6344.